Fernández-Núñez T, Amghar-Maach S, Gay-Escoda C. Efficacy of botulinum toxin in the treatment of bruxism: Systematic review. Med Oral Patol Oral Cir Bucal. 2019 Jul 1;24 (4):e416-24.   

 

doi:10.4317/medoral.22923

http://dx.doi.org/doi:10.4317/medoral.22923

___________________________________________________________________________________________________________________________________________________________________________________________

 

References

1. Lobbezoo F, Ahlberg J, Glaros AG, Kato T, Koyano K, Lavigne GJ et al. Bruxism defined and graded: An international consensus. J Oral Rehabil. 2013;40: 2-4.
https://doi.org/10.1111/joor.12011
PMid:23121262

 

 

 

2. Manfredini D, Winocur E, Guarda-Nardini L, Paesani D, Lobbezoo F. Epidemiology of bruxism in adults: A systematic review of the literature. J Orofac Pain. 2013;27:99-110.
https://doi.org/10.11607/jop.921

 

 

 

3. Koyano K, Tsukiyama Y, Ichiki R, Kuwata T. Assessment of bruxism in the clinic. J Oral Rehabil. 2008;35:495-508.
https://doi.org/10.1111/j.1365-2842.2008.01880.x
PMid:18557916

 

 

 

4. Bader G, Kampe T, Tagdae T. Body movement during sleep in subjects with long-standing bruxing behavior. Int J Prosthodont. 2000;13:327-33.

 

 

 

5. Manfredini D, Lobbezoo F. Relationship between bruxism and temporomandibular disorders: A systematic review of literature from 1998 to 2008. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010;109:e25-50.
https://doi.org/10.1016/j.tripleo.2010.02.013
PMid:20451831

 

 

 

6. Pierce CJ, Chrisman K, Bennett ME et al. Stress, anticipatory stress, and psychologic measures re- lated to sleep bruxism. J Orofac Pain. 1995;9:51-6.

 

 

 

7. Rugh JD, Barghi N, Drago CJ. Experimental occlusal discrepancies and nocturnal bruxism. J Prosthet Dent. 1984;51:548-53.
https://doi.org/10.1016/0022-3913(84)90312-3

 

 

 

8. Lobbezoo F, Naeije M. Bruxism is mainly regulated centrally, not peripherally. J Oral Rehabil. 2001;28:1085-91.
https://doi.org/10.1046/j.1365-2842.2001.00839.x
PMid:11874505

 

 

 

9. Klasser GD, Rei N, Lavigne GJ. Sleep bruxism etiology: The evolution of a changing paradigm. J Can Dent Assoc. 2015;81:f2.

 

 

 

10. Okeson JP. The effects of hard and soft occlusal splints on nocturnal bruxism. J Am Dent Assoc. 1987;114:788-91.
https://doi.org/10.14219/jada.archive.1987.0165
PMid:3475357

 

 

 

11. Saletu A, Parapatics S, Saletu B, Anderer P, Prause W, Putz H y cols. On the pharmacotherapy of sleep bruxism: Placebo-controlled polysomnographic and psychometric studies with clonazepam. Neuropsychobiology. 2005;51:214-25.
https://doi.org/10.1159/000085917
PMid:15915004

 

 

 

12. Pirazzini M, Rossetto O, Eleopra R, Montecucco C. Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology. Pharmacol Rev. 2017;69:200-35.
https://doi.org/10.1124/pr.116.012658
PMid:28356439 PMCid:PMC5394922

 

 

 

13. Urrútia G, Bonfill X. PRISMA declaration: A proposal to improve the publication of systematic reviews and meta-analyses. Med Clin (Barc). 2010;135:507-11.
https://doi.org/10.1016/j.medcli.2010.01.015
PMid:20206945

 

 

 

14. SIGN 50: A guideline developer's handbook publication 50 [updated November 2015]. In: Scottish Intercollegiate Guidelines Network (SIGN), Edinburgh. Available from http://www.sign.ac.uk.

 

 

 

15. Cochrane handbook for systematic reviews of interventions version 5.1.0 [updated March 2011]. In: Higgins JPT, Green S, editors. The Cochrane collaboration. Available from www.cochrane-handbook.org.

 

 

 

16. Al-Wayli H. Treatment of chronic pain associated with nocturnal bruxism with botulinum toxin. A prospective and randomized clinical study. J Clin Exp Dent. 2017;9:e112-17.
https://doi.org/10.4317/jced.53084
PMid:28149474 PMCid:PMC5268105

 

 

 

17. Zhang LD, Liu Q, Zou DR, Yu LF. Occlusal force characteristics of masseteric muscles after intramuscular injection of botulinum toxin A (BTX - A) for treatment of temporomandibular disorder. Br J Oral Maxillofac Surg. 2016;54:736-40.
https://doi.org/10.1016/j.bjoms.2016.04.008
PMid:27138229

 

 

 

18. Lee SJ, McCall WD Jr, Kim YK, Chung SC, Chung JW. Effect of botulinum toxin injection on nocturnal bruxism: A randomized controlled trial. Am J Phys Med Rehabil. 2010;89:16-23.
https://doi.org/10.1097/PHM.0b013e3181bc0c78
PMid:19855255

 

 

 

19. Guarda-Nardini L, Manfredini D, Salamone M, Salmaso L, Tonello S, Ferronato G. Efficacy of botulinum toxin in treating myofascial pain in bruxers: A controlled placebo pilot study. Cranio. 2008;26:126-35.
https://doi.org/10.1179/crn.2008.017
PMid:18468272

 

 

 

20. Blitzer A, Sulica L. Botulinum toxin: Basic science and clinical uses in otolaryngology. Laryngoscope. 2001;111:218-26.
https://doi.org/10.1097/00005537-200102000-00006
PMid:11210864

 

 

21. Yin S, Stucker FJ, Nathan CO. Clinical application of botulinum toxin in otolaryngology, head and neck practice (brief review). J La State Med Soc. 2001;153:92-97.

 

 

 

22. Kato T, Thie NM, Huynh N, Miyawaki S, Lavigne GJ. Topical review: Sleep bruxism and the role of peripheral sensory influences. J Orofac Pain. 2003;17:191-213.

 

 

 

23. Lavigne GJ, Huynh N, Kato T, Okura K, Adachi K, Yao D y cols. Genesis of sleep bruxism: Motor and autonomic-cardiac interactions. Arch Oral Biol. 2007;52:381-4.
https://doi.org/10.1016/j.archoralbio.2006.11.017
PMid:17313939

 

 

 

24. Rao LB, Sangur R, Pradeep S. Application of Botulinum toxin type A: An arsenal in dentistry. Indian J Dent Res. 2011;22:440-45.
https://doi.org/10.4103/0970-9290.87068
PMid:22048586

 

 

 

25. Fuster Torres MA, Berini Aytés L, Gay Escoda C. Salivary gland application of botulinum toxin for the treatment of sialorrhea. Med Oral Patol Oral Cir Bucal. 2007;12:511-7.

 

 

 

26. Alonso-Navarro H, Jiménez-Jiménez FJ, Plaza-Nieto JF, Pilo-De la Fuente B, Navacerrada F, Arroyo-Solera M y cols. Treatment of severe bruxism with botulinum toxin type A. Rev Neurol. 2011;53:73-6.
https://doi.org/10.33588/rn.5302.2011017
PMid:21720976

 

 

 

27. Kim YK, Kim SG, Im JH, Yun PY. Clinical survey of the patients with temporomandibular joint disorders, using Research Diagnostic Criteria (Axis II) for TMD: Preliminary study. J Craniomaxillofac Surg. 2012;40:366-72.
https://doi.org/10.1016/j.jcms.2011.05.018
PMid:21745749

 

 

 

28. Ihde SK, Konstantinovic VS. The therapeutic use of botulinum toxin in cervical and maxillofacial conditions: An evidence-based review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104:e1-11.
https://doi.org/10.1016/j.tripleo.2007.02.004
PMid:17560141

 

 

 

29. Tan EK, Jankovic J. Treating severe bruxism with botulinum toxin. J Am Dent Assoc. 2000;131:211-16.
https://doi.org/10.14219/jada.archive.2000.0149

 

 

 

30. Monroy PG, Da Fonseca MA. The use of botulinum toxin-A in the treatment of severe bruxism in a patient with autism: A case report. Spec Care Dentist. 2006;26:37-39.
https://doi.org/10.1111/j.1754-4505.2006.tb01508.x